XINGANJIANG
873167
INNOVATIVE DATA
835305
CHENGUANG MEDICAL
430300
4
Hangzhou Gaoxin Materials Technology
300478
5
Beijing Philisense Technology
300287
US Stock MarketDetailed Quotes
OMIC Singular Genomics
- 19.960
- +0.020+0.10%
Close Feb 14 16:00 ET
- 19.960
- 0.0000.00%
Post 20:01 ET
50.64MMarket Cap-0.58P/E (TTM)
19.960High19.830Low5.18KVolume19.860Open19.940Pre Close103.11KTurnover0.28%Turnover RatioLossP/E (Static)2.54MShares23.41052wk High0.41P/B37.13MFloat Cap5.34052wk Low--Dividend TTM1.86MShs Float1001.100Historical High--Div YieldTTM0.65%Amplitude5.340Historical Low19.894Avg Price1Lot Size
Trending Stocks
Discussing
Big Tech’s earnings season in full swing! Nvidia is the only one left
On Thursday, $Amazon (AMZN.US)$ stock fell after the firm reported Q4 adjusted earnings of $1.86/share, vs estimates of $1.50/share, on reve
Moo Earnings
Feb 2 12:39
AMZN earnings preview: Grab rewards by guessing the opening price!
Singular Genomics Stock Forum
Singular Genomics Enters into Agreement to be Acquired by Deerfield for $20.00 in Cash per Share
Monday, 23rd December at 8:30 am
SAN DIEGO, Dec. 23, 2024 (GLOBE NEWSWIRE) -- Singular Genomics Systems, Inc. (NASDAQ: OMIC) ("Singular Genomics" or the "Company"), a company leveraging novel next-generation sequencing (NGS) and spatial multiomics technologies to empower researchers and clinicians, today announced that it has entered into a definitive merger agreement...
📊⚡️📊
Singular Genomics | SC 13D/A: Statement of acquisition of beneficial ownership by individuals (Amendment)-Deerfield Mgmt IV, L.P.(6.66%),Deerfield Private Design Fund IV, L.P.(6.66%), etc.
SEC·
Singular Genomics Receives Non-Binding Acquisition Proposal from Concentra Biosciences and Tang Capital
SAN DIEGO, Sept. 19, 2024 (GLOBE NEWSWIRE) -- Singular Genomics Systems, Inc. (NASDAQ:OMIC), a company leveraging novel next-generation sequencing (NGS) and spatial multiomics technologies to empower researchers and clinicians, announced today that it has received an unsolicited non-binding proposal from Concentra Biosciences, LLC ("Concentra") to acquire all o...
No comment yet